Form 4: CME Group Executive Suzanne Sprague Reports Stock Transactions

Suzanne Sprague, Sr MD Global Head of Clearing at CME Group, reports acquisition and disposal of company stock to cover tax obligations related to performance share awards and restricted stock vesting.

Summary

• On March 15, 2024, Suzanne Sprague, Sr MD Global Head of Clearing at CME Group, reported transactions involving CME Group Class A Common Stock.
• Sprague acquired 561 shares at a price of $217.5 per share related to a 2020 performance share award.
• She disposed of 249 shares and 81 shares at $217.5 per share to fulfill tax withholding obligations related to the performance share award and vesting of restricted stock, respectively.
• Following these transactions, Sprague beneficially owns 7,203 shares of CME Group Class A Common Stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the document simply reports stock transactions by an executive, which is a routine and expected disclosure.

Industry Context

This filing is a routine disclosure of stock transactions by a company executive, which is common in publicly traded companies. It provides transparency into the executive's holdings and transactions in the company's stock.

Comparison to Industry Standards

• Form 4 filings are standard practice for corporate insiders at publicly traded companies like CME Group, similar to filings made by executives at Intercontinental Exchange (ICE) or Nasdaq, Inc.
• The transactions reported, involving stock awards and tax-related disposals, are typical forms of compensation and compliance seen across the financial industry.

Stakeholder Impact

• The transactions have a minimal direct impact on stakeholders, as they are related to executive compensation and tax obligations.
• The filing provides transparency to shareholders regarding insider transactions.

Key Dates